Liberty Biopharma (CVE:LTY) Share Price Passes Above 50 Day Moving Average – Here’s Why

Liberty Biopharma Inc (CVE:LTY) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.

Liberty Biopharma Price Performance

The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The business has a 50 day simple moving average of C$2.00 and a 200-day simple moving average of C$2.00. The firm has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66.

Liberty Biopharma Company Profile

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.